Clinical Trial: Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Study Status: Completed
Recruit Status: RECRUITING
Condition: Systemic Lupus Erythematosus (Sle)
Study Type: OBSERVATIONAL
Official Title: Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Brief Summary:
Background:Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males.People with SLE are often treated with cyclophosphamide (CYC).But CYC can damage a woman s ovaries; it may cause infertility.A drug called GnRHa is sometimes given to protect the ovaries during CYC therapy.But no one really knows how effective GnRHa treatment is.This natural history survey will compare women who received GnRHa during CYC therapy with those who did not.Objective:To find out whether GnRHa…
Read more